Related Experiment Video
Updated: Sep 6, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
International electronic health record-derived post-acute sequelae profiles of COVID-19 patients
Harrison G Zhang1, Arianna Dagliati2, Zahra Shakeri Hossein Abad1
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Insights
Post-acute sequelae of COVID-19 (PASC) present diverse cardiovascular and neurological risks. This large international study identified new-onset conditions in COVID-19 survivors, highlighting PASC
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Post-acute sequelae of COVID-19 (PASC) risk profiles remain incompletely understood globally.
- Large-scale, multi-national studies with appropriate controls are needed to characterize PASC.
- Electronic Health Record (EHR) data offers a valuable resource for studying long-term COVID-19 effects.
Purpose of the Study:
- To systematically identify new-onset conditions associated with COVID-19 in the post-acute period.
- To characterize the cardiovascular, neurological, and metabolic risk profiles of PASC.
- To compare PASC incidence across inpatient and outpatient COVID-19 cohorts.
Main Methods:
- Leveraged EHR data from 277 international hospitals.
- Analyzed data from 414,602 COVID-19 patients and 2.3 million controls.
- Utilized over 221 million diagnosis codes to identify enriched conditions post-COVID-19.
Main Results:
- Inpatient COVID-19 cases showed increased risk for angina pectoris, heart failure, cognitive dysfunction, and fatigue.
- Outpatient COVID-19 cases faced higher risks of pulmonary embolism, venous embolism, atrial fibrillation, type 2 diabetes, and vitamin D deficiency.
- Outpatient cases also experienced increased risks for loss of smell/taste, inflammatory neuropathy, and cognitive dysfunction.
Conclusions:
- PASC is associated with significant cardiovascular and neurological sequelae.
- The study identified distinct risk profiles for inpatient and outpatient COVID-19 survivors.
- Findings underscore the multifaceted nature of PASC, impacting multiple organ systems.
Abstract:
The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well characterized in multi-national settings with appropriate controls. We leveraged electronic health record (EHR) data from 277 international hospitals representing 414,602 patients with COVID-19, 2.3 million control patients without COVID-19 in the inpatient and outpatient settings, and over 221 million diagnosis codes to systematically identify new-onset conditions enriched among patients with COVID-19 during the post-acute period. Compared to inpatient controls, inpatient COVID-19 cases were at significant risk for angina pectoris (RR 1.30, 95% CI 1.09-1.55), heart failure (RR 1.22, 95% CI 1.10-1.35), cognitive dysfunctions (RR 1.18, 95% CI 1.07-1.31), and fatigue (RR 1.18, 95% CI 1.07-1.30). Relative to outpatient controls, outpatient COVID-19 cases were at risk for pulmonary embolism (RR 2.10, 95% CI 1.58-2.76), venous embolism (RR 1.34, 95% CI 1.17-1.54), atrial fibrillation (RR 1.30, 95% CI 1.13-1.50), type 2 diabetes (RR 1.26, 95% CI 1.16-1.36) and vitamin D deficiency (RR 1.19, 95% CI 1.09-1.30). Outpatient COVID-19 cases were also at risk for loss of smell and taste (RR 2.42, 95% CI 1.90-3.06), inflammatory neuropathy (RR 1.66, 95% CI 1.21-2.27), and cognitive dysfunction (RR 1.18, 95% CI 1.04-1.33). The incidence of post-acute cardiovascular and pulmonary conditions decreased across time among inpatient cases while the incidence of cardiovascular, digestive, and metabolic conditions increased among outpatient cases. Our study, based on a federated international network, systematically identified robust conditions associated with PASC compared to control groups, underscoring the multifaceted cardiovascular and neurological phenotype profiles of PASC.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...